Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-26 @ 12:26 AM
Study NCT ID:
NCT01534260
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2012-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
Sponsor:
Hamid Sayar
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-13
First Submit QC Date:
None
Study First Post Date:
2012-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-21
Results First Submit QC Date:
None
Results First Post Date:
2018-08-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-20
Last Update Post Date:
2018-08-17
Last Update Post Date Type:
ACTUAL